Entera Bio Ltd (ENTX)

Entera Bio Ltd Stock (ENTX) Financials Data

*All numbers in millions

Period End Date	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Period Length	3 Months	3 Months	3 Months	3 Months	3 Months
Revenues	-	-	-	-	-
Cost Of Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
	59.22%7.27	4.56	3.54	3.04	3.26
Selling, General, and Administrative	26.61%0.16	0.12	0.13	0.05	0.12
Research and Development	53.86%4.93	3.20	2.25	1.72	1.64
Operating Income/Loss	59.22%-7.27	-4.56	-3.54	-3.04	-3.26
Nonoperating Income/Loss	203.09%-8.33	-2.75	0.03	0.03	0.06
	113.31%-15.60	-7.31	-3.51	-3.02	-3.20
Attributable To Parent	113.31%-15.60	-7.31	-3.51	-3.02	-3.20
Basic Average Shares	187.56%145.08	50.45	47.76	-	47.09
Diluted Average Shares	187.56%145.08	50.45	47.76	-	47.09
Basic Earnings Per Share	21.43%0.11	0.14	0.07	-	0.07
Diluted Earnings Per Share	21.43%0.11	0.14	0.07	-	0.07